One study reported lower LINE-1 methylation levels in glioblastomas compared to low-grade gliomas, and higher LINE-1 methylation levels were associated with MGMT promoter methylation and longer survival of glioblastoma patients [33]. Here, MGMT is linked to central nervous system cancer.